49 results
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
skilled personnel;
the costs associated with being a public company;
the amount of revenue, if any, received from commercial sales of our product
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
skilled personnel;
the costs associated with being a public company;
the amount of revenue, if any, received from commercial sales of our product
424B5
SEEL
Seelos Therapeutics Inc
25 Sep 23
Prospectus supplement for primary offering
6:02am
and distribution costs;
the expenses needed to attract and retain skilled personnel;
the costs associated with being a public company;
the amount of revenue
424B5
qkip54 z3t
12 May 22
Prospectus supplement for primary offering
8:30am
424B5
b183ale
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
lv2rq6kl14ou6vpqt7ha
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
upsrjbh
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
vbj8r0092cvxbpv
25 Jan 21
Prospectus supplement for primary offering
4:16pm